Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Filings indexed 1,562 across all filing types
Latest filing 2023-03-30 Regulatory Filings
Country TW Taiwan
Listing TW 1760

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
111年度存貨週轉率
Regulatory Filings Classification · 95% confidence The document is very short (281 characters) and contains a brief table with inventory turnover rates and average sales days for two fiscal years (110 and 111). There is no detailed financial data, analysis, or narrative typical of a full financial report. It appears to be a simple disclosure or explanation related to inventory turnover changes. Given the brevity and nature of the content, it does not qualify as an Annual Report, Interim Report, or any detailed financial filing. It is more likely a Regulatory Filing (RNS) as a general disclosure or compliance announcement without substantive financial statements or management discussion.
2023-03-30 Chinese
111年度毛利率
Fund Information / Factsheet Classification · 85% confidence The document is very short (388 characters) and contains a simple financial summary table with annual revenue, cost, gross profit, and gross margin percentages for two years. It includes a note about explaining significant changes in gross margin. There is no detailed financial statement, management discussion, or comprehensive report content. The document appears to be a brief financial data disclosure or summary rather than a full report. Given the brevity and nature of the content, it does not qualify as an Annual Report (10-K), Interim Report (IR), or Management Report (MDA). It is more consistent with a Fund Information / Factsheet (FS) or a Regulatory Filing (RNS) due to its summary nature. However, since it is a brief summary of key financial figures, the best fit is Fund Information / Factsheet (FS).
2023-03-30 Chinese
111年度營益分析
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data for multiple fiscal periods including quarterly (first quarter, half-year, third quarter) and full-year results. It includes metrics such as operating revenue, gross margin, operating profit margin, pre-tax profit margin, and after-tax profit margin for several years. The presence of actual financial figures and analysis for partial fiscal periods (quarters and half-year) indicates this is a comprehensive interim or quarterly financial report rather than a brief announcement or summary. The document length is relatively short (1040 characters), but it contains substantive financial data, so it is not merely a report publication announcement or regulatory filing. Therefore, the document best fits the category of an Interim / Quarterly Report (IR). FY 2022
2023-03-30 Chinese
111年第4季權益變動表
Interim / Quarterly Report Classification · 85% confidence The document contains detailed tables showing changes in equity, including items such as common stock capital, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, treasury stock, and total equity attributable to the parent company and non-controlling interests. The data is presented for the current period (year 111 in the ROC calendar, corresponding to 2022) and the previous period (year 110). The document is titled as a 'Consolidated Statement of Changes in Equity' and includes financial figures in thousands of New Taiwan Dollars. This type of detailed financial statement is typically part of a comprehensive financial report rather than a brief announcement or a certification. The document length is 3903 characters, which is relatively short but contains substantive financial data. Given the nature of the content, it is consistent with a component of an Interim or Quarterly Report (IR), which includes actual financial statements and analysis for a period shorter than a full fiscal year. There is no indication that this is an announcement of a report or a certification letter, nor is it a standalone audit report or a regulatory filing. Therefore, the most appropriate classification is Interim / Quarterly Report (IR). FY 2022
2023-03-30 Chinese
111年第4季現金流量表
Interim / Quarterly Report Classification · 85% confidence The document contains a consolidated cash flow statement with detailed financial data for the fiscal year 111 (2022) and comparisons to the previous year. It includes line items such as net income before tax, depreciation, amortization, changes in working capital, investing and financing activities, and cash balances. The presence of comprehensive financial statements and substantive financial data for a specific fiscal period indicates this is a financial report rather than a brief announcement or certification. The document length is 2620 characters, which is relatively short but contains actual financial data, not just a notice or link to a report. Given the detailed financial data for a full fiscal year, this aligns best with an Annual Report (10-K) or similar annual financial report. However, since the document is a consolidated cash flow statement only and does not include the full annual report text, it is more appropriate to classify it as an Interim / Quarterly Report (IR) if it is for a quarter or partial year, or Annual Report (10-K) if it is for the full year. The document states it is for the 4th quarter of year 111, which suggests it is a quarterly or interim report. Therefore, the best classification is Interim / Quarterly Report (IR). FY 2022
2023-03-30 Chinese
111年第4季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the fourth quarter of the 111th year (which corresponds to 2022 in the Gregorian calendar) and compares it with the previous year. It includes detailed financial data such as revenue, costs, expenses, net profit, and earnings per share. The presence of actual financial statements and substantive financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 2280 characters, which is relatively short but contains detailed financial data, so it is not merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). FY 2022
2023-03-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.